arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Vivani Medical, Inc.

VANI

$1.05 ▼ -0.02 (-2.33%) at close

14 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Vivani Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $65.5M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -138.4% →

FCF / Share $-0.41 ↘

Trailing P/E —

Price / Book 5.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-26.61M

↓ -13.3% —

Operating Margin Operating profit as % of sales

-359.2%

↓ -60.4% —

FCF / Share Free cash flow per share

$-0.41

↓ -5.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	-51.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-738%)	-13.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-268%)	99.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1148%)	-55.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-793%)	163.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1942%)	117.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1364%)	—	—
EPS Growth YoY (%)	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	14.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-13.3% Weak ↑ Weak Improving Year-over-year change in net income	8.4% Fair ↑ Fair Improving Year-over-year change in net income	-84.7% Weak ↓ Weak Declining Year-over-year change in net income	-55.7% Weak ↓ Weak Declining Year-over-year change in net income	40.0% Excellent ↑ Excellent Improving Year-over-year change in net income	55.7% Excellent ↑ Excellent Improving Year-over-year change in net income	4.3% Caution ↑ Caution Improving Year-over-year change in net income	-23.1% Weak ↓ Weak Declining Year-over-year change in net income	14.1% Fair ↑ Fair Improving Year-over-year change in net income	-65.7% Weak ↓ Weak Declining Year-over-year change in net income	43.1% Excellent Excellent Year-over-year change in net income	-53.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-5.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	-5.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-8.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	32.8% Excellent Excellent Compound annual revenue growth over 3 years	36.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	-0.1% Weak Weak Compound annual revenue growth over 5 years	34.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	-359.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2495%)	—	-224.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1593%)	—	—	—
Effective Tax Rate (%) (%)	—	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	-358.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3084%)	—	-223.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1964%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	-434.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-304.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-138.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-140.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-102.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1751.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-368.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-901.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-286.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-235.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-78.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	154.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-70.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-334.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-204.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-329.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-197.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-197.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-49.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-169.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1228%)	-133.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-989%)	-123.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-924%)	-31.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-309%)	-13.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	—	—	—	—	-297.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2084%)	-98.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-759%)	-101.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-778%)	249.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1561%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Net Debt (USD)	$-16.23M	$-18.35M	$-20.65M	$-45.08M	$-69.59M	$-3.18M	$-11.33M	$-4.47M	$-7.84M	—	$-239.00K	$-619.00K	$-62.00K	$-145.00K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.43	$-0.43	$-0.50	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.41	$-0.39	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.21	$0.30	$0.41	—	—	—	$0.47	$0.04	$0.14	$0.26	—	—	—	—
Tangible Book Value per Share (USD)	$0.21	$0.30	$0.41	—	—	—	$0.47	$0.04	$0.14	$0.26	—	—	—	—
Basic Weighted Avg Shares (shares)	62.39M	54.98M	50,853	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$11.30M	$14.46M	$17.34M	$40.71M	$68.05M	$-863.00K	$6.15M	$2.02M	$6.55M	$9.62M	$18.78M	$33.52M	—	—
Total Equity (USD)	$15.73M	$17.61M	$20.76M	$44.31M	$68.36M	$-672.00K	$7.28M	$3.08M	$7.88M	$11.15M	$20.26M	$34.62M	$-9.22M	$-3.04M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	—	—	—	—	—	$3.38M	$6.90M	$7.96M	$3.98M	$8.95M	$3.40M	$1.56M	—
Depreciation Expense (USD)	$424.00K	$400.00K	$357.00K	$381.00K	$70.00K	$164.00K	$397.00K	$435.00K	$457.00K	$432.00K	$335.00K	$279.00K	$316.00K	—
Net Income, GAAP (USD)	$-26.61M	$-23.49M	$-25.65M	$-13.89M	$-8.92M	$-14.88M	$-33.59M	$-35.09M	$-28.52M	$-33.18M	$-20.02M	$-35.20M	$-22.97M	—
Operating Cash Flow (USD)	$-24.32M	$-20.79M	$-23.70M	$-18.79M	$-9.19M	$-16.82M	$-27.63M	$-29.81M	$-23.95M	$-25.07M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 52 quarters

Vivani Medical, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VANI with peers